Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Endo is our partner.........
View:
Post by somweyungguy on Nov 19, 2015 11:53pm

Endo is our partner.........

Endo is BIG and smart.  Endo controls Valstar....why doesn't Endo trade in chemo based Valstar with little efficacy for the non-toxic, more efficacious MCNA?

An interesting discussion...."Indeed"

GLTA
Sqr
Comment by DamnYankees on Nov 20, 2015 12:23am
Or Endo throws a buck on the table, we get a 5 bagger from here, Valstarocidin hits the refractory market June 1 and BC suffers have another bullet in the two barrelled pistol. Wouldn't surprise me in the least !
Comment by somweyungguy on Nov 20, 2015 7:57am
I have seen very little about ENDO mentioned. @I do remember the last phase III ending right in the middle of tax loss season ( that@s a same ) @I believe ENDO will be at our side on the 27th of Feb.@ Endo is our partner......... Endo is BIG and smart. @Endo controls Valstar....why doesn@t Endo trade in chemo based Valstar with little efficacy for the non-toxic, more efficacious MCNA? An ...more  
Comment by DamnYankees on Nov 20, 2015 8:12am
In hindsight how many people here would have wanted ENDO heavies at that meeting on MCNA's behalf? It would've have been their first walk out of the bullpen and Brand and Horsepower, like it or not, matters. maybe as much as much as the evidence itself.  To many here ( Canadians) ENDO is an evil entity from the past. What they miss is that when MCNA hits the market it will be ENDO ...more  
Comment by rgonlyfactspls on Nov 20, 2015 8:43am
DamnYankees...there is no question that Telesta "going alone" in the U.S. is swimming against the current. Not suggesting it's not possible to obtain an FDA approval, just would be a rare instance a biotech of its size and resources has been approved. I assume their recent U.S. equity partnerships might have provided some helping hand (insights, knowledge, resources) but only an ...more  
Comment by DamnYankees on Nov 20, 2015 8:49am
RGF, according to our only semi public analyst we are going to FDA approval as a penny stock sub 100 mil company. Yes that is the current guidance. A F;:&$ing penny stock flying solo submitting for a bladder cancer marketing license. We got em right we want em boys! And I was accused of bashing when I said a US partner  was an absolute necessity. Had people that mattered shared that ...more  
Comment by 18tee20 on Nov 20, 2015 12:28pm
I agree in that I think a lot of the negative bias and the "no" votes are a result of Telesta attempting to go it alone in the U.S.  It wouldn't surprise me any if this isn't an extemely relevant factor in these U.S. voting members extreme negative arguments and associated voting results. I would add that I don't think Endo is any champion in Telesta's ...more  
Comment by ragingbull1327 on Nov 20, 2015 12:33pm
Exactly.   But how does this explain their behaviour?  why would the FDA *FAST-TRACK* it twice if they didn't see its potential?    We didn't have ENDO when we submitted BLA and they STILL fast-tracked it.   This doesn't make sense.   They're trying to derail a treatment based on too narrow a scope
Comment by ragingbull1327 on Nov 20, 2015 12:35pm
ENDOs involvement is likely not over.   They may still try and take this over because the pipeline is still better than theirs is when it comes to this kind of therapy.    I think too many people are giving credit to the big shareholder who sets the price.   They're wrong.   They're just betting you won't take the shares off the table.    Wrong again. ...more  
Comment by DamnYankees on Nov 20, 2015 12:34pm
Endo could take out Telesta tomorrow for less than 1 years revenue with a near 100% probability of having MCNA in the market place with 6-8 months. Make no mistake about that. They park Valstar and throw the keys in MCNA. Endo is watching very closely. That I know.
Comment by ragingbull1327 on Nov 20, 2015 12:45pm
My next investment, Mason Graphite, will hopefully not be as much of a roller coaster chitshow as this ride has been.   And this company is trying to save lives.    Mason Graphite will likely beat them to the market with graphene
Comment by somweyungguy on Nov 20, 2015 8:24am
ENDI will obviously play a HUGE  role....stay tuned...think staright...don't let the "bullboard program" hellp shake you out... Endo is our partner......... Endo is BIG and smart.  Endo controls Valstar....why doesn't Endo trade in chemo based Valstar with little efficacy for the non-toxic, more efficacious MCNA? An interesting discussion...."Indeed"  ...more  
Comment by ragingbull1327 on Nov 20, 2015 10:04am
ENDO did play a roll.  They efffed up the trial we had designed and went with their own ideas.   If this was done by design, in order to benefit in some other way from our product, and they end up buying us in the end, I won't be shocked, but I will be disgusted.   It wouldn't surprise me at all..... if you're going to play this game, play it faster please....  
Comment by ragingbull1327 on Nov 20, 2015 10:14am
Is having ENDO efffing up our trial not a justifiable excuse as to why enrolment sucked, or does nobody want to hear that,   Also, is it not a conflict of interest to sabotage a treatments approval that is direct competition to something in their own pipeline?   No? 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities